Neuroprotection by the stable nitroxide Tempol during reperfusion in a rat model of transient focal ischemia
- 1 April 2000
- journal article
- research article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 92 (4), 646-651
- https://doi.org/10.3171/jns.2000.92.4.0646
Abstract
The use of thrombolytic agents in the treatment of stroke has yielded surprisingly modest success, possibly because of reperfusion injury mediated by reactive oxygen species (ROS). Therefore, scavenging ROS may be of therapeutic value in the treatment of stroke. Nitroxides are low-weight superoxide dismutase mimics, which allows them to act as cell-permeable antioxidants. In this study the nitroxide 4-hydroxy-2,2,6,6,-tetramethylpiperidine-1-oxyl (Tempol) is investigated to determine its ability to reduce reperfusion injury. Male Sprague-Dawley rats weighing between 280 g and 350 g underwent middle cerebral artery occlusion with an intraluminal suture for 60 minutes. Regional cerebral blood flow, blood pressure, cerebral temperature, and rectal temperature were monitored during the procedure. After reperfusion, the animals were randomized to groups receiving blinded intravenous administration of either Tempol (10 mg/kg; eight animals) or vehicle (eight animals) over the first 20 minutes of reperfusion (Study I). In a second study to determine dose dependency, animals were randomized to groups receiving Tempol (20 mg/kg; eight animals), low-dose Tempol (5 mg/kg; eight animals), or vehicle (eight animals; Study II). The rats were killed after 4 hours of reperfusion, and brain sections were stained with 2,3,5 triphenyltetrazolium chloride. Infarct volumes were measured using digital imaging. Animals receiving Tempol had significantly reduced infarct volumes at doses of 20 mg/kg and 10 mg/kg compared with controls (49.01+/-18.22% reduction [p = 0.003] and 47.47+/-34.57 [p = 0.02], respectively). No significant differences in the physiological variables measured were observed between groups. Tempol provides significant neuroprotection after reperfusion in a rat model of transient focal ischemia. These results support the importance of ROS in reperfusion injury and encourage further study of this molecule as a therapeutic agent following thrombolysis.Keywords
This publication has 20 references indexed in Scilit:
- Attenuation of Ischemia-Reperfusion Injury in the Rat Neocortex by the Hydroxyl Radical Scavenger NicaravenNeurosurgery, 1997
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Detection of Free Radical Activity During Transient Global Ischemia and Recirculation: Effects of Intraischemic Brain Temperature ModulationJournal of Neurochemistry, 1995
- Modulation of streptonigrin cytotoxicity by nitroxide sod mimicsFree Radical Biology & Medicine, 1994
- Delayed treatment with the spin trap α‐phenyl‐N‐tert‐butyl nitrone (PBN) reduces infarct size following transient middle cerebral artery occlusion in ratsActa Physiologica Scandinavica, 1994
- Nitroxide-Stimulated H2O2Decomposition by Peroxidases and PseudoperoxidasesFree Radical Research Communications, 1992
- Nitroxides block DNA scission and protect cells from oxidative damageBiochemistry, 1991
- Biologically active metal-independent superoxide dismutase mimicsBiochemistry, 1990
- Central nervous systems trauma and stroke: I. Biochemical considerations for oxygen radical formation and lipid peroxidationFree Radical Biology & Medicine, 1989
- Oxygen-Derived Free Radicals in Postischemic Tissue InjuryNew England Journal of Medicine, 1985